265 analyst ratings (weighted) · Buy
S&P 500 Sector Rotation: Where Analyst Targets Imply the Most Upside
Independent analysis of Wall Street analyst target-price upside across 11 S&P 500 sectors as of May 27, 2026. See which sectors lead and lag on consensus implied upside in our 110-stock watchlist.
Read article →This page provides a comprehensive analysis of large-cap stocks within the Healthcare sector. Compare target prices, upside potential, and key financial metrics to identify promising investment opportunities.
| Ticker | Price | Avg Target | Upside | Market Cap | P/E Ratio (TTM) | Beta (Volatility) | Opinion |
|---|---|---|---|---|---|---|---|
DHR Danaher Corporation 23 · Strong Buy | $172.81 | $247.83 | +43.41% | $122.31B | 33.49 | 0.84 | strong buy |
ABT Abbott Laboratories 25 · Buy | $86.67 | $118.64 | +36.89% | $150.96B | 24.28 | 0.65 | buy |
TMO Thermo Fisher Scientific Inc 25 · Strong Buy | $448.18 | $611.56 | +36.45% | $166.55B | 24.63 | 0.88 | strong buy |
ABBV AbbVie Inc. 29 · Buy | $213.12 | $252.90 | +18.66% | $376.54B | 103.96 | 0.30 | buy |
LLY Eli Lilly and Company 29 · Buy | $1064.74 | $1211.03 | +13.74% | $949.47B | 37.86 | 0.48 | buy |
PFE Pfizer, Inc. 27 · Buy | $25.85 | $29.19 | +12.91% | $147.33B | 19.73 | 0.30 | buy |
JNJ Johnson & Johnson 24 · Buy | $230.18 | $252.96 | +9.90% | $554.09B | 26.70 | 0.26 | buy |
MRK Merck & Company, Inc. 27 · Buy | $119.72 | $129.74 | +8.37% | $295.69B | 33.72 | 0.20 | buy |
UNH UnitedHealth Group Incorporated 26 · Buy | $376.86 | $395.15 | +4.85% | $342.24B | 28.36 | 0.65 | buy |
AMGN Amgen Inc. 30 · Buy | $335.94 | $352.23 | +4.85% | $181.31B | 23.35 | 0.43 | buy |
When investing in the Healthcare sector, consider the average upside potential and the consensus of Wall Street analysts. Pay attention to the P/E ratio and Beta to understand the valuation and volatility of each stock relative to the broader market.
A. Based on Wall Street analyst consensus, the Healthcare sector currently has an average upside of +19.0% across 10 large-cap stocks.
A. Danaher Corporation (DHR) leads with +43.4% upside. Consensus target price is $247.83 vs. current price of $172.81.
A. All sector data is refreshed once daily via an automated workflow. Analyst target prices and recommendations are sourced from Yahoo Finance.